Top 5 Wellness VC Funds & Investors in Taiwan (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Suzhou Industrial Park Nankai Venture Capital
VC Fund
|
1 | Taiwan | Series A | Wellness, Health Care, Consumer Research | |
|
Panacea Venture
VC Fund
|
1 | China, United States, Taiwan | Series A, Seed | Biotechnology, Health Care, Medical | $1.4M–$50M |
|
Guangzhou Yuexiu Industrial Investment Fund
VC Fund
|
1 | China, United States, Taiwan | Series B, Series C, Series A | Manufacturing, Biotechnology, Health Care | $1.4M–$600M |
|
Zero2IPO Ventures
VC Fund
|
1 | China, Taiwan, India | Series A, Series B, Angel | E-Commerce, Internet, Education | $142k–$42M |
|
Sino Biopharmaceutical
VC Fund
|
1 | China, United States, Israel | Series D, Series B, Seed | Biotechnology, Health Care, Medical | $27M–$400M |
| Access all 10 VC funds in Taiwan Wellness startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Investor list
Suzhou Industrial Park Nankai Venture Capital is engaged in venture capital business.
Show more...Investment focus
- Industry: Wellness, Health Care, Consumer Research
- Stage:Series A
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
Discover Panacea Venture - a global healthcare fund driving innovation in biotech. Transforming lives through investments. Explore our portfolio and strategy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed
- Geography: China, United States, Taiwan
Investor stats
- Total investments: 22
- Round size: Seed $13M–$50M; Series A $1.4M–$20M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
- Human Longevity — Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California.
- Eos BioInnovation — Discover Eos Bioinnovation's commitment to advancing sustainable biotechnology through innovative research and development. Explore our mission and services.
Guangzhou Yuexiu Industrial Investment Fund is a corporate investment arm of Yue Xiu Enterprises (Holdings) Limited.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Series B, Series C, Series A
- Geography: China, United States, Taiwan
Investor stats
- Total investments: 79
- Round size: Series A $1.4M–$600M; Series B $10M–$142M; Series C $25M–$170M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- HjMicro — Hongjun Microelectronics is committed to the development of "higher efficiency and easier deployment" server processor (CPU) chips based on the ARM architecture, mainly for the data center cloud computing market.
- CSR Biotech — CSR Biotech is a biological research company that provides cell imaging and data processing services.
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
Zero2IPO Ventures is the venture investment arm under Zero2IPO Group targeted at high-potential, high-growth China enterprises. Leveraging Zero2IPO's vast network in China, Zero2IPO Ventures does not compete with other venture funds, but rather pursue a two-prong investment strategy, i.e. to co-invest with active venture capital firms ingrowth and late stage companies and to lead or co-lead in early stage startups in China. The industry focus includes Internet, mobile and wireless applications, digital media, healthcare, green-tech, consumable products and services, as well as other emerging sectors. We intend to leverage the extensive network that has been created by Zero2IPO Group, a leading venture capital and private equity market research and financial advisory company, to seek out potential investment opportunities and provide a strong value-add to our portfolio companies. Through its venture capital and private equity surveys, investment forums, training programs, and investment advisory services, Zero2IPO Group has developed a strong reputation in the China market for helping entrepreneurs connect with investors.
Show more...Investment focus
- Industry: E-Commerce, Internet, Education
- Stage:Series A, Series B, Angel
- Geography: China, Taiwan, India
Investor stats
- Total investments: 86
- Round size: Angel $142k–$1.4M; Series A $1.4M–$29M; Series B $2.9M–$42M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $40M in 2014
Portfolio highlights
- Makera — Makera builds the smartest desktop CNC machines for makers. Explore our Carvera series, versatile mill routers, and rich case templates for every project.
- Xuntu Technology — Xuntu Technology is a leading data intelligence provider specializing in investment research and decision-making solutions.
- Ruidong New Energy — Ruidong New Energy provides power systems for new energy and electric vehicles. The company specializes in the design and manufacture of power systems for new energy and energy-efficient automobiles.
Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemicalmedicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series D, Series B, Seed
- Geography: China, United States, Israel
Investor stats
- Total investments: 11
- Round size: Series B $91M–$110M; Series D $27M–$400M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Sanegene Bio — Sanegene Bio is currently operating in stealth mode.
- PaiLin Biotech — PaiLin Biotech is a specialized blood product provider focused on the production, collection, storage, and sales of high-quality single-donor plasma.
- Phrontline Biopharma — Phrontline Biopharma specializes in the development of ADC to address unmet medical needs in the field of oncology.
Wellness VC funding in Taiwan at a glance
Stats across 5 deals from 10 investors.
Access all 10 VC funds in Taiwan Wellness startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Wellness VC Funds in Taiwan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 10 VC funds investing in Taiwan Wellness startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Sign up with Google
Sign up with LinkedIn
